Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario.

Pharmaceutical and healthcare stocks had the strongest rally during Covid period, with the sectoral index BSE Healthcare skyrocketing over 125 per cent in just 15-16 months. After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario. 

A meeting on the Covid situation was conducted by the Union Health Ministry in response to reports of an increase in Covid cases in China, Japan, the United States of America and Brazil. Morepen Laboratories, Nectar Lifesciences and Syncom Formulations (India) Ltd were a few of the stocks that experienced consecutive gains. 

Here is a list of the top pharmaceutical sector multi-baggers that impressed investors with their outstanding returns!  

The pharmaceutical industry in India contributes an enormous economic contribution to the country and is significant to the global pharmaceutical industry, coming in third place globally in terms of production volume and fourteenth in terms of value. 

India is renowned for producing high-quality generic drugs and vaccines at reasonable prices. With a 20 per cent share of all pharmaceutical exports worldwide, India is the largest volume supplier of generic medications in the world. India is the world's 12th largest exporter of medical goods. More than 50 per cent of all vaccines produced globally are supplied by it, making it the leading vaccine supplier globally in terms of volume. 

Stay tuned to know more about the prospects of various sectors and the potential multi-baggers in those areas!